We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.15B
1-Year Est. Return 13.14%
This Fund
S&P 500
This Quarter Est. Return
-13.65%
1 Year Est. Return
+13.14%
3 Year Est. Return
+63.19%
5 Year Est. Return
+70.18%
10 Year Est. Return
+417.82%
AUM
$7.97B
AUM Growth
-$1.21B
Cap. Flow
+$169M
Cap. Flow %
2.12%
Top 10 Hldgs %
71.87%
Holding
92
New
8
Increased
40
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$21.5M
2
PRVA icon
Privia Health
PRVA
+$17M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$15.2M
4
HDB icon
HDFC Bank
HDB
+$15M
5
MSFT icon
Microsoft
MSFT
+$9.84M

Sector Composition

Rank Sector Weight
1 Financials 20.81%
2 Healthcare 17.36%
3 Technology 16.88%
4 Consumer Discretionary 15.11%
5 Communication Services 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
51
Insmed
INSM
$28.3B
$6.77M 0.08%
343,110
KPTI icon
52
Karyopharm Therapeutics
KPTI
$36.5M
$6.76M 0.08%
100,000
CHRS icon
53
Coherus Oncology
CHRS
$205M
$6.72M 0.08%
928,464
DBX icon
54
Dropbox
DBX
$7.73B
$6.52M 0.08%
310,566
+32,050
+12% +$693K
COO icon
55
Cooper Companies
COO
$10.3B
$6.17M 0.08%
78,876
+8,140
+12% +$720K
AOS icon
56
A.O. Smith
AOS
$7.8B
$6M 0.08%
109,818
+11,339
+12% +$680K
RMD icon
57
ResMed
RMD
$31.5B
$5.82M 0.07%
27,748
+2,864
+12% +$610K
TRU icon
58
TransUnion
TRU
$14.9B
$5.69M 0.07%
71,179
+7,335
+11% +$631K
TDOC icon
59
Teladoc Health
TDOC
$1.12B
$5.58M 0.07%
168,000
TVRD
60
Tvardi Therapeutics
TVRD
$24.9M
$5.33M 0.07%
16,207
EA
61
DELISTED
Electronic Arts
EA
$4.98M 0.06%
40,918
-12,645
-24% -$1.61M
PTC icon
62
PTC
PTC
$14.2B
$4.96M 0.06%
46,594
+4,808
+12% +$519K
VRSK icon
63
Verisk Analytics
VRSK
$22.9B
$4.75M 0.06%
27,423
+2,827
+11% +$527K
ALLE icon
64
Allegion
ALLE
$13B
$4.46M 0.06%
45,593
+4,709
+12% +$511K
GPN icon
65
Global Payments
GPN
$23.4B
$4.27M 0.05%
38,572
+3,983
+12% +$504K
MSCI icon
66
MSCI
MSCI
$40.3B
$4M 0.05%
9,709
+1,003
+12% +$437K
MELI icon
67
Mercado Libre
MELI
$96.2B
$3.51M 0.04%
5,518
+470
+9% +$410K
HRTX icon
68
Heron Therapeutics
HRTX
$59.9M
$3.35M 0.04%
1,202,069
XYL icon
69
Xylem
XYL
$25B
$3.21M 0.04%
41,055
+4,234
+11% +$350K
CGNX icon
70
Cognex
CGNX
$10.8B
$3M 0.04%
70,491
+7,269
+11% +$407K
TYL icon
71
Tyler Technologies
TYL
$13.8B
$2.77M 0.03%
8,338
+860
+12% +$315K
G icon
72
Genpact
G
$5.9B
$2.38M 0.03%
56,253
+28,908
+106% +$1.23M
BEPC icon
73
Brookfield Renewable
BEPC
$5.71B
$2.18M 0.03%
61,256
OR icon
74
OR Royalties Inc
OR
$6.75B
$2.14M 0.03%
212,091
ICE icon
75
Intercontinental Exchange
ICE
$88.4B
$2.05M 0.03%
21,799
+6,893
+46% +$737K

Similar funds

C WorldWide Group's Q2 2022 Portfolio in Review

As of Q2 2022, C WorldWide Group held 92 positions worth $7.97B, down 13% from $9.18B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

C WorldWide Group's Q2 2022 filing shows 8 new, 40 increased, 6 reduced and 1 closed positions. Its largest new stake was Outset Medical: 50,000 shares worth $11.1M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $10.2M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • C WorldWide Group's largest Q2 2022 buy was Outset Medical: 50,000 shares worth $11.1M.
  • C WorldWide Group added most to HDFC Bank in Q2 2022, an estimated $15M increase.
  • C WorldWide Group's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $10.2M.
  • C WorldWide Group fully exited TherapeuticsMD in Q2 2022, selling an estimated $2.35M.
  • C WorldWide Group's ten largest holdings make up 72% of its $7.97B portfolio in Q2 2022.
  • C WorldWide Group opened 8 new positions and closed 1 in Q2 2022.
  • C WorldWide Group's portfolio value fell 13% quarter-over-quarter to $7.97B.

Based on C WorldWide Group's 13F filing for Q2 2022, filed 2 Aug 2022.